X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Draft Reflection Paper On AI In Medicines Published By EMA

Content Team by Content Team
26th July 2023
in News
Draft Reflection Paper On AI In Medicines Published By EMA

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The European Medicines Agency- EMA went on to publish a draught reflecting paper dated July 19, which detailed out the agency’s present outlook when it comes to the usage of artificial intelligence so as to support safe as well as effective development, regulation, and also the use of human and veterinary drugs. The paper, which is now all out for public discussion, highlights the recommendations when it comes to the usage of Artificial Intelligence and Machine Learning across any step of the drug’s lifecycle, right from its discovery to the post-authorization setting.

As per the EMA’s press release, both AI and ML tools have it in them to effectively support the acquisition, analysis, transformation, and interpretation of data throughout the lifecycle of the medicinal product. Their application can go on to include AI as well as ML modelling approaches so as to replace, lessen, and refine the usage of animal models across preclinical development.

It is well to be noted that during the clinical trials’ stage, AI as well as ML systems can go on to assist with data recording and also its analyses, which can be submitted to regulators when it comes to marketing authorization procedures. Apparently, during the stage of marketing authorization, AI has tools so as to draft, translate, compile as well as review data that happens to be used in the product information of a drug. When it comes to the post-authorization stage, these tools can go on to potentially support pharmacovigilance actions.

The reflection paper stresses that a human-driven approach has to be at the forefront when it comes to all creation as well as the rollout of AI and ML. The total usage of AI must be in line with present legal requirements and also take into consideration ethics and fundamental rights’ respect into account.

The co-chair of the HMA-EMA Big Data Steering Group and the director of the Data Analytics Centre at the Danish Medicines Agency, Jasper Kjær said that the fact is that the use of AI is phenomenally developing in society, and as regulators, they see more applications when it comes to the medical field. It brings with it exciting options to create new insights and enhance processes. To have them entirely, they will have to be well-versed in the regulatory issues that are presented by a rapidly evolving ecosystem.

EMA also recommends that developers must look out for early regulatory support when it comes to AI and ML systems. As per Peter Arlett, who happens to be head of Data Analytics and Methods at EMA and BDSG’s co-chair, with this paper, they are indeed opening a dialogue with developers, other regulators, and academics to seek a way forward, making sure that the full potential of these innovations can be availed for the benefit of patients and also animal health.

The paper happens to be part of an initiative by BDSG to create the capability of the European Medicines Regulatory Network in regulation that is data-driven. It was created in collaboration with the EMA’s Committee for Veterinary Medicinal Products, the Committee for Medicinal Products for Human Use, and the BDSG.

Previous Post

Next-Gen Platforms To Make Pharma Supply Chains More Able

Next Post

AI-Powered Quality Management In Pharma And Medtech Sectors

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post
AI - Powered Quality Management In Pharma And Medtech Sectors

AI-Powered Quality Management In Pharma And Medtech Sectors

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In